Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients With Colorectal Cancer

Oncology - Switzerland
doi 10.1159/000443377
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Electroneurography in the Evaluation of Oxaliplatin-Induced Neuropathy in Colorectal Cancer Patients

Neoplasma
Cancer Research
2016English

Impact of Oxaliplatin-Induced Neuropathy in Patients With Colorectal Cancer: A Prospective Evaluation at a Single Institution

Current Oncology
Oncology
2015English

Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2017English

Longitudinal Assessment of Oxaliplatin-Induced Neuropathy

Neurology
Neurology
2011English

Genetic Polymorphisms of SCN9A Are Associated With Oxaliplatin-Induced Neuropathy

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients

Nutrients
NutritionFood ScienceDietetics
2018English

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Supraspinal Role of Protein Kinase C in Oxaliplatin-Induced Neuropathy in Rat

Pain
NeurologyAnesthesiologyPain MedicinePharmacology
2009English

A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy